PROGENICS PHARMACEUTICALS IN's ticker is and the CUSIP is 743187956. A total of 3 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $1,000 | -96.0% | 5 | -90.0% | 0.00% | – |
| Q4 2019 | $25,000 | +108.3% | 50 | +100.0% | 0.00% | – |
| Q3 2019 | $12,000 | -89.2% | 25 | -86.1% | 0.00% | – |
| Q2 2019 | $111,000 | +326.9% | 180 | +210.3% | 0.00% | – |
| Q1 2019 | $26,000 | +271.4% | 58 | +205.3% | 0.00% | – |
| Q4 2018 | $7,000 | -36.4% | 19 | 0.0% | 0.00% | – |
| Q3 2018 | $11,000 | -89.5% | 19 | -85.5% | 0.00% | – |
| Q2 2018 | $105,000 | +377.3% | 131 | -32.1% | 0.00% | -100.0% |
| Q1 2018 | $22,000 | +2100.0% | 193 | +1508.3% | 0.00% | – |
| Q4 2017 | $1,000 | -50.0% | 12 | -94.2% | 0.00% | – |
| Q3 2017 | $2,000 | 0.0% | 208 | +593.3% | 0.00% | – |
| Q2 2017 | $2,000 | -66.7% | 30 | -6.2% | 0.00% | – |
| Q1 2017 | $6,000 | 0.0% | 32 | -31.9% | 0.00% | – |
| Q4 2016 | $6,000 | +500.0% | 47 | +20.5% | 0.00% | – |
| Q3 2016 | $1,000 | 0.0% | 39 | 0.0% | 0.00% | – |
| Q2 2016 | $1,000 | – | 39 | -39.1% | 0.00% | – |
| Q1 2016 | $0 | – | 64 | +6300.0% | 0.00% | – |
| Q4 2015 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2015 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2015 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2014 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 31,000 | $177,000 | 0.00% |
| Citadel Advisors | 12,800 | $73,000 | 0.00% |
| SIMPLEX TRADING, LLC | 1 | $0 | 0.00% |